These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 3047437)

  • 1. Flow cytometric determination of ploidy in prostatic adenocarcinoma: a comparison with seminal vesicle involvement and histopathological grading as a predictor of clinical recurrence.
    Lee SE; Currin SM; Paulson DF; Walther PJ
    J Urol; 1988 Oct; 140(4):769-74. PubMed ID: 3047437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA in radical prostatectomy specimens. Prognostic value of tumor ploidy.
    Robertson CN; Paulson DF
    Acta Oncol; 1991; 30(2):205-7. PubMed ID: 2029406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of pathologic stage and postprostatectomy disease recurrence by DNA ploidy analysis of initial needle biopsy specimens of prostate cancer.
    Ross JS; Figge H; Bui HX; del Rosario AD; Jennings TA; Rifkin MD; Fisher HA
    Cancer; 1994 Nov; 74(10):2811-8. PubMed ID: 7954242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deoxyribonucleic acid ploidy analysis as a predictor of recurrence following radical prostatectomy for stage T2 disease.
    Carmichael MJ; Veltri RW; Partin AW; Miller MC; Walsh PC; Epstein JI
    J Urol; 1995 Mar; 153(3 Pt 2):1015-9. PubMed ID: 7853549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of nuclear DNA ploidy patterns in patients with prostate cancer after radical prostatectomy.
    Wirth MP; Müller HA; Manseck A; Müller J; Frohmüller HG
    Eur Urol; 1991; 20(3):248-52. PubMed ID: 1823048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of prostate cancer nuclear deoxyribonucleic acid, size, shape and Gleason grade with pathological stage at radical prostatectomy.
    Epstein JI; Pizov G; Steinberg GD; Carter HB; Pitcock R; Armas OA; Partin A; Walsh PC
    J Urol; 1992 Jul; 148(1):87-91. PubMed ID: 1613888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stage C prostatic adenocarcinoma: flow cytometric nuclear DNA ploidy analysis.
    Nativ O; Winkler HZ; Raz Y; Therneau TM; Farrow GM; Myers RP; Zincke H; Lieber MM
    Mayo Clin Proc; 1989 Aug; 64(8):911-9. PubMed ID: 2796401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seminal vesicle biopsy: accuracy and implications for staging of prostate cancer.
    Linzer DG; Stock RG; Stone NN; Ratnow R; Ianuzzi C; Unger P
    Urology; 1996 Nov; 48(5):757-61. PubMed ID: 8911521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometric analysis of comedocarcinoma of the prostate: an uncommon histopathological variant of prostatic adenocarcinoma.
    Currin SM; Lee SE; Walther PJ
    J Urol; 1988 Jul; 140(1):96-100. PubMed ID: 2837590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perineural invasion and seminal vesicle involvement predict pelvic lymph node metastasis in men with localized carcinoma of the prostate.
    Stone NN; Stock RG; Parikh D; Yeghiayan P; Unger P
    J Urol; 1998 Nov; 160(5):1722-6. PubMed ID: 9783940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescence in situ hybridization aneuploidy as a predictor of clinical disease recurrence and prostate-specific antigen level 3 years after radical prostatectomy.
    Brown JA; Slezak JM; Lieber MM; Jenkins RB
    Mayo Clin Proc; 1999 Dec; 74(12):1214-20. PubMed ID: 10593349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA content in prostatic adenocarcinoma. A flow cytometry study of the predictive value of aneuploidy for tumor volume, percentage Gleason grade 4 and 5, and lymph node metastases.
    Jones EC; McNeal J; Bruchovsky N; de Jong G
    Cancer; 1990 Aug; 66(4):752-7. PubMed ID: 2386903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression and survival in prostatic adenocarcinoma: a comparison of clinical stage, Gleason grade, S-phase fraction and DNA ploidy.
    Vesalainen S; Nordling S; Lipponen P; Talja M; Syrjänen K
    Br J Cancer; 1994 Aug; 70(2):309-14. PubMed ID: 8054280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Needle biopsy DNA ploidy status predicts grade shifting in prostate cancer.
    Ross JS; Sheehan CE; Ambros RA; Nazeer T; Jennings TA; Kaufman RP; Fisher HA; Rifkin MD; Kallakury BV
    Am J Surg Pathol; 1999 Mar; 23(3):296-301. PubMed ID: 10078920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of seminal vesicle involvement due to prostate cancer in radical prostatectomy specimens.
    Algarra R; Barba J; Merino I; Tienza A; Tolosa E; Robles JE; Zudaire J
    Actas Urol Esp; 2015 Apr; 39(3):144-53. PubMed ID: 24996780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of clinical stage, serum prostatic acid phosphatase and preoperative Gleason grade with final pathological stage in 275 patients with clinically localized adenocarcinoma of the prostate.
    Oesterling JE; Brendler CB; Epstein JI; Kimball AW; Walsh PC
    J Urol; 1987 Jul; 138(1):92-8. PubMed ID: 3599229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow cytometric assessment of deoxyribonucleic acid content in renal adenocarcinoma: does ploidy status enhance prognostic stratification over stage alone?
    Currin SM; Lee SE; Walther PJ
    J Urol; 1990 Mar; 143(3):458-63. PubMed ID: 2304153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular invasion predicts recurrence after radical prostatectomy: stratification of risk based on pathologic variables.
    Ferrari MK; McNeal JE; Malhotra SM; Brooks JD
    Urology; 2004 Oct; 64(4):749-53. PubMed ID: 15491714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
    Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
    Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA ploidy and prostate-specific antigen as prognostic factors in clinically resectable prostate cancer.
    Badalament RA; O'Toole RV; Young DC; Drago JR
    Cancer; 1991 Jun; 67(12):3014-23. PubMed ID: 1710533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.